Analysis of longitudinally obtained HIV-1 env sequences from an individual with reported cross-reactive neutralizing activity revealed that the majority of viral variants obtained from serum between 4 and 7 years after seroconversion were unable to persist in peripheral blood. Here we show that these viral variants were more sensitive to autologous serum neutralization, had shorter envelopes with fewer potential N-linked glycosylation sites, and showed lower replication kinetics than successfully evolving HIV-1 variants. These data reflect the host selection pressures on phenotypic characteristics of HIV-1 and illustrate in detail the dynamic interaction between HIV-1 and its host's humoral immune responses
Antibodies that neutralize (nAbs) genetically diverse HIV-1 strains have been recovered from a subse...
Background: The first stages of HIV-1 infection are essential to establish the diversity of virus po...
Understanding human immunodeficiency virus type 1 (HIV-1) transmission is central to developing effe...
Analysis of longitudinally obtained HIV-1 env sequences from an individual with reported cross-react...
Most human immunodeficiency virus type 1 (HIV-1)-infected individuals develop an HIV-specific neutra...
A substantial proportion of human immunodeficiency virus type 1 (HIV-1)-infected individuals has cro...
AbstractObjectivesHIV is able to continuously adapt to and evade the evolving neutralizing antibody ...
AbstractThe origin of broadly neutralizing HIV-specific antibodies and their relation to HIV evoluti...
<div><p>We compared the neutralization sensitivity of early/transmitted HIV-1 variants from patients...
Human immunodeficiency virus type 1 (HIV-1) has the ability to adapt to the host environment by esca...
Recent evidence of the evolutionary adaptation of HIV-1 to the specific immune system is reviewed. L...
AbstractAutologous HIV-1-specific neutralizing antibodies (NAbs) seem unable to inhibit viral replic...
Studies of viruses taken from individuals with broad cross-neutralizing antibodies against primary i...
The rapid and continual viral escape from neutralizing antibodies is well documented in HIV-1 infect...
BackgroundThe evolution of HIV-1 and its immune escape to autologous neutralizing antibodies (Nabs) ...
Antibodies that neutralize (nAbs) genetically diverse HIV-1 strains have been recovered from a subse...
Background: The first stages of HIV-1 infection are essential to establish the diversity of virus po...
Understanding human immunodeficiency virus type 1 (HIV-1) transmission is central to developing effe...
Analysis of longitudinally obtained HIV-1 env sequences from an individual with reported cross-react...
Most human immunodeficiency virus type 1 (HIV-1)-infected individuals develop an HIV-specific neutra...
A substantial proportion of human immunodeficiency virus type 1 (HIV-1)-infected individuals has cro...
AbstractObjectivesHIV is able to continuously adapt to and evade the evolving neutralizing antibody ...
AbstractThe origin of broadly neutralizing HIV-specific antibodies and their relation to HIV evoluti...
<div><p>We compared the neutralization sensitivity of early/transmitted HIV-1 variants from patients...
Human immunodeficiency virus type 1 (HIV-1) has the ability to adapt to the host environment by esca...
Recent evidence of the evolutionary adaptation of HIV-1 to the specific immune system is reviewed. L...
AbstractAutologous HIV-1-specific neutralizing antibodies (NAbs) seem unable to inhibit viral replic...
Studies of viruses taken from individuals with broad cross-neutralizing antibodies against primary i...
The rapid and continual viral escape from neutralizing antibodies is well documented in HIV-1 infect...
BackgroundThe evolution of HIV-1 and its immune escape to autologous neutralizing antibodies (Nabs) ...
Antibodies that neutralize (nAbs) genetically diverse HIV-1 strains have been recovered from a subse...
Background: The first stages of HIV-1 infection are essential to establish the diversity of virus po...
Understanding human immunodeficiency virus type 1 (HIV-1) transmission is central to developing effe...